Are you Dr. Friedman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1636 E 14th St
Ste 120
Brooklyn, NY 11229Phone+1 718-339-2300Fax+1 718-998-8020
Summary
- Dr. Simon Friedman, MD is an otolaryngologist in Brooklyn, New York. He is currently licensed to practice medicine in New York. He is affiliated with Mount Sinai Brooklyn.
Education & Training
Zucker School of Medicine at Hofstra/NorthwellResidency, Otolaryngology - Head and Neck Surgery, 1980 - 1983
One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Surgery, 1979 - 1980- Brookdale University Hospital and Medical CenterResidency, Obstetrics and Gynecology, 1978 - 1979
Maimonides Medical CenterInternship, Internal Medicine, 1977 - 1978
State University of New York Downstate Medical Center College of MedicineClass of 1977
Certifications & Licensure
NY State Medical License 1978 - 2026- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
Publications & Presentations
PubMed
- 58 citationsLight-activated RNA interference using double-stranded siRNA precursors modified using a remarkable regiospecificity of diazo-based photolabile groupsSamit Shah, Piyush K. Jain, Ashish Kala, Dipu Karunakaran, Simon H. Friedman
Nucleic Acids Research. 2009-07-01 - 23 citationsAn ESI-MS method for characterization of native and modified oligonucleotides used for RNA interference and other biological applicationsSamit Shah, Simon H. Friedman
Nature Protocols. 2008-01-01 - 151 citationsLight-activated RNA interference.Samit Shah, Subhashree Rangarajan, Simon H. Friedman
Angewandte Chemie. 2005-02-18
Press Mentions
Beams of Light to Treat Diabetes: UMKC Invention Gets Federal Funding BoostJuly 8th, 2020
Grant Support
- Synthetic And Analytical Methods Targeting TelomeraseNational Cancer Institute2003–2007
- Fullerene Based Inhibitors Of HIV 1 Protease: Structure Based DesignNational Center For Research Resources1999–2001
- Fullerene Based Inhibitors Of HIV 1 ProteaseNational Center For Research Resources1997–1999
- RNA/DNA Binding Molecules As Telomerase InhibitorsNational Institute Of General Medical Sciences1996–1999
Professional Memberships
- Fellow
